Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.53
-0.23 (-6.12%)
At close: Aug 15, 2025, 3:59 PM
3.50
-0.85%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonnet BioTherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -13.56M | -13.29M | -9.43M | -7.44M | -7.99M | -8.43M | -14.46M | -18.83M | -22.59M | -26.52M | -29.06M | -29.72M | -29.24M | -27.48M | -25.31M | -24.98M | -25.55M | -31.22M | -26.97M |
Depreciation & Amortization | 88.05K | 86.93K | 85.33K | 83.11K | 80.97K | 78.91K | 77.29K | 75.75K | 74.21K | 78.93K | 86.24K | 93.26K | 100.11K | 100.49K | 97.81K | 95.16K | 92.61K | 90.29K | 894.14K |
Stock-Based Compensation | -110.4K | -50.01K | 10.39K | n/a | 220.8K | 210.41K | 207.01K | 248.63K | 284.13K | 342.02K | 635.91K | 876.37K | 1.11M | 1.32M | 1.34M | 1.38M | 1.43M | 1.11M | 768.11K |
Other Working Capital | -384.57K | 1.46M | 886.22K | -1.94M | -1.76M | -2.94M | -2.41M | -484.31K | -948.71K | 376.77K | -385.24K | -877.58K | -1.17M | -1.71M | -1.64M | -637.73K | 821.27K | 702.13K | -643.32K |
Other Non-Cash Items | 3.39M | 1.1M | 615.35K | 578.57K | 716K | 145.22K | 157.22K | 282K | 12.98K | 797.85K | 951.48K | 971.48K | -21.56M | -22.14M | -22.31M | -22.43M | -7.13M | -1.59M | -1.17M |
Deferred Income Tax | n/a | n/a | n/a | 36.77K | -331.85K | 36.77K | 36.77K | n/a | 368.62K | n/a | n/a | n/a | 22.43M | 22.3M | 22.3M | 22.3M | 7M | 7.13M | 7M |
Change in Working Capital | -123.58K | 525.09K | 292.13K | -1.87M | -2.7M | -5.14M | -4.54M | -3.12M | -1.09M | 705.71K | 1.88M | 93.46K | -305.65K | 414.33K | -1.79M | 1.09M | 2M | 1.64M | 529K |
Operating Cash Flow | -10.31M | -11.62M | -8.43M | -8.61M | -10M | -13.1M | -18.52M | -21.34M | -22.94M | -24.6M | -25.51M | -27.69M | -27.46M | -25.48M | -25.66M | -22.55M | -22.16M | -22.83M | -18.95M |
Capital Expenditures | n/a | -12K | -12K | -12K | -182K | -182K | -443.25K | -443.25K | -297.85K | -872.1K | -776.48K | -896.48K | -875.5K | -289.25K | -123.62K | -3.62K | 21.75K | 10.83K | -8.88K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -12K | -24K | -12K | -12K | -12K | -12K | -12K | -12K | 49.65K | -524.6K | -690.23K | -810.23K | -875.5K | -289.25K | -123.62K | -3.62K | n/a | n/a | n/a |
Investing Cash Flow | -12K | -24K | -12K | -12K | -182K | -182K | -443.25K | -443.25K | -297.85K | -872.1K | -776.48K | -896.48K | -875.5K | -289.25K | -123.62K | -3.62K | 21.75K | 10.83K | -8.88K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.12K | -19.62K | -19.62K | -19.62K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.78M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -650.94K | 2.12M | 2.47M | 2.56M | 2.77M | 1.8M | 1.81M | 1.81M | 3.99M | 2.17M | 2.17M | 2.17M | n/a | n/a | 10.18M | 10.18M | 19.96M | 29.33M | 21.16M |
Financial Cash Flow | 7.09M | 9.92M | 10.28M | 6.49M | 6.71M | 5.68M | 20.28M | 21.01M | 25.04M | 23.22M | 8.58M | 4.01M | 27.53M | 32.67M | 42.85M | 42.83M | 25.09M | 29.31M | 21.14M |
Net Cash Flow | -3.23M | -1.73M | 1.84M | -2.12M | -3.47M | -7.6M | 1.32M | -778.62K | 1.8M | -2.25M | -17.71M | -24.57M | -813.59K | 6.9M | 17.06M | 20.27M | 2.93M | 6.47M | 2.12M |
Free Cash Flow | -10.31M | -11.63M | -8.44M | -8.62M | -10.18M | -13.28M | -18.96M | -21.79M | -23.24M | -25.47M | -26.29M | -28.58M | -28.34M | -25.77M | -25.79M | -22.56M | -22.14M | -22.82M | -18.96M |